dence of a survival benefit of continuous hemodiafiltration dialysis for acute renal failure, compared with IHD. This study did not control for other major Background. Acute renal failure (ARF) requiring dialysis clinical decisions or other supportive management strategies in critically ill patients is associated with an in-hospital mortalthat are widely variable (for example, nutrition support, hemoity rate of 50 to 80%. The worldwide standard for renal replacedynamic support, timing of initiation, and dose of dialysis) and ment therapy is intermittent hemodialysis (HID). Continuous hemight materially influence outcomes in ARF. Standardization modialysis and hemofittration techniques have recently emerged of several aspects of care or extremely large sample sizes will as alternative modalities. These two therapies have not been be required to answer optimally the questions originally posed directly compared, by this investigation. Methods. A multicenter, randomized, controlled trial was conducted comparing two dialysis modalities (IHD vs. continuous hemodiafiltration) for the treatment of ARF in the intensive care unit (ICU). One hundred sixty-six patients were randomDespite advances in intensive care unit (ICU) and diaized. Principal outcome measures were ICU and hospital motlytic technology over the past four decades, mortality rates tality, length of stay, and recovery of renal function, associated with acute renal failure (ARF) remain distressResults. Using intention-to-treat analysis, the overall ICU and ingly high. Depending on the etiology of ARF and comorin-hospital mortalities were 50.6 and 56.6%, respectively. Conbid conditions, in-hospital mortality rates range from ap. tinuous therapy was associated with an increase in ICU (59.5 vs. 41.5 %, P < 0.02) and in-hospital (65.5 vs. 47.6%, P < 0.02) proximately 30% in nephrotoxic drug-induced ARF to 90% mortality relative to intermittent dialysis. Median ICU length or more when ARF is accompanied by respiratory, heof stay from the time of nephrology consultation was 16.5 days, patic, or other organ system failure [1-4]. The worldwide and complete recovery of renal function was observed in 34.9% standard of care for ARF requiring dialysis in the ICU of patients, with no significant group differences. Despite ranis intermittent hemodialysis (IHD). Continuous hemodidomization, there were significant differences between the groups in several covariates independently associated with alysis, hemofiltration, and hemodiafiltration techniques mortality, including gender, hepatic failure, APACHE II and [hereafter termed continuous renal replacement thera-III scores, and the number of failed organ systems, in each pies (CRRT)] have recently emerged as alternative diainstance biased in favor of the intermittent dialysis group. Using lytic modalities for critically ill patients with severe ARF. logistic regression to adjust for the imbalances in group assignTo date, published comparisons of CRRT and IHD ment, the odds of death associated with continuous therapy was 1.3 (95% CI, 0.6 to 2.7, P = NS). A detailed investigation have shown favorable trends in survival, improved conof the randomization process failed to explain the marked trol of volume overload and azotemia, and greater hemodifferences in patient assignment, dynamic stability with CRRT, although most have comConclusions. A randomized controlled trial of alternative pared CRRT in centers with extensive experience to dialysis modalities in ARF is feasible. Despite the potential adhistorical controls [5] [6] [7] [8] . No direct controlled comparivantages of continuous techniques, this study provides no evisons have been made between these two therapies.
comes in ARF. The sample size was determined based crylonitrile) membranes were employed in IHD patients. on the hypothesis that CRRT would result in a reduction
The duration of IHD treatments was determined by the in ICU mortality for ARF requiring dialysis from 70 to nephrologist based on an estimate of the catabolic state, 50% with two-tailed tx = 0.05 and 1-[3 = 0.80. and ranged from three to four hours. Fluid removal per session was prescribed on an evaluation of fluid status METHODS with an aim to optimize fluid balance. When available, estimates of fluid balance were guided by central venous Study subjects pressure or pulmonary capillary wedge pressures. We considered all adult ICU patients with ARF in Hemodiafiltration (hemodialysis + hemofiltration) was whom a nephrology service consultation was obtained prescribed for all patients in the CRRT arm. During the at four academic medical centers in Southern California first two years of the study, continuous arteriovenous he-(University of California, San Diego; U.S. Naval Medical modiafiltration (CAVHDF) with arteriovenous access Center, San Diego; Veterans Administration Medical (single-lumen catheters placed in the femoral artery Center, San Diego; and University of California, Irvine, and a central vein) was performed. Thereafter, continu-CA, USA) between January 1991 and September 1995.
ous venovenous hemodiafiltration (CVVHDF) was pre-ARF was defined using standard laboratory parameters, scribed, using one of two available pump-driven devices For patients with no prior history of kidney disease or available laboratory values, ARF was defined by a blood (Hospal BSM-22 pump; Hospal Inc., Lyon, France; and Baxter BM-11; Baxter Inc., MeGaw Park, IL, USA) and urea nitrogen (BUN) ->40 mg/dL (140 p,mol/L) or a a dual-lumen intravenous catheter. Hemodiafiltration serum creatinine of ->2.0 mg/dL (177 txmol/L). For patients with available baseline laboratory values, ARF was accomplished using polysulfone or polyacrylonitrile was defined by a sustained rise in serum creatinine of membranes, blood flow rates of 100 mL/min, dialysate ->1 mg/dL (88.4 p_mol/L) compared with baseline. Paflow rates of 16.7 mL/min (1 L/hour), and ultrafiltration tients were deemed to have pre-existing chronic renal rates of 400 to 800 mL/hour. The desired fluid balance insufficiency (CRI) if they had a baseline creatinine of was maintained by administration of an hourly infusion ->2.0 rag%. A patient was considered for enrollment if rate of replacement fluid given prefllter. Systemic hepain the judgment of the treating nephrologist he or she rin, regional citrate, or saline flushes were variably emrequired dialysis and if the mean arterial blood pressure ployed for anticoagulation in CRRT, depending on the was >70 mm Hg with or without pressor support in the treating physician's judgment and hospital protocol. Paeight hours preceding randomization. Exclusion criteria tients were permitted to cross over from one therapy to included previous dialysis for acute or chronic renal failthe other based on the following criteria: (1) lack of ure, kidney transplantation, ARF from urinary tract obadequate arterial vascular access for CAVHDF (CRRT struction, or a volume-responsive prerenal state. Indicato IHD), (2) intolerance of the procedure (inability to tions for dialysis were similar at all four centers and perform an adequate dialysis treatment because of inincluded uremia, electrolyte abnormality, diuretic unretradialytic hypotension despite use of fluid boluses and sponsive fluid overload, acid-base imbalance, and a pressors; IHD to CRRT), (3) need for mobility (requiremarked catabolic state, for example, burns. Informed ment for patient to be out of bed in a chair; CRRT to consent was obtained from all study participants or their IHD), or (4) transfer from the ICU (CRRT to IHD). next of kin. The study was approved by the institutional As the duration of dialysis was variable, an adequate trial review boards of all participating hospitals. Patients were of therapy was defned as a minimum exposure of 25 hours followed prospectively from the time of initial nephrolfor CRRT and two treatments of three hours or more of ogy service consultation through hospital discharge, duration each for IHD.
Treatment assignments
Clinical data Patients at each center were randomized to IHD or CRRT with the intervention assignment generated by a Baseline vital signs, hemodynamic, and laboratory data were recorded for the first ICU day (most extreme vatcomputerized random number generator with separate lists at each center. Dialysis treatment was initiated in ues) and every day (every 12 hours) from the time of all patients by the consulting nephrologist. IHD was pernephrology consultation. Serial Acute Physiology and formed using ultrafiltration-controlled machines, hepaChronic Health Evaluation (APACHE) II and III scores fin anticoagulation, bicarbonate-based dialysate, dialywere computed for each day in the ICU to assess change sate flow rates of 500 mL/min, and blood flow rates of 200 in severity of illness [9, 10] . We determined the number to 300 mL/min using temporary dual-lumen catheters, of organ systems in failure (OSF) based on a modification Cellulosic (cuprophan, cellulose acetate) and noncelluof the criteria of Seneff and Knaus [10] . The criteria losic (polysulfone, polymethylmethacrylate, and polyaused for each OSF [11] are described in the Appendix. (2) patients who crossed over from one treatment to another. Two-tailed P values (N = 2), lack of familiarity with study procedures (N = 3), and unsuitable patient for social reasons (N = 2). <0.05 were considered statistically significant.
Definitions
The 82 patients who were excluded by the physicians were further compared with those who were randomized, RESULTS and no significant differences were seen at the time of Study participants and randomization consultation in the key demographic variables shown in Table 1 (data not shown). The 166 randomized patients At the four centers participating in the trial, 718 paenrolled are included in the analyses presented here. Of tients were consulted on for 746 episodes of ARF and the 166 patients randomized, 82 were assigned to IHD 374 patients were dialyzed. Of these, 166 (44.4%) were and 84 were assigned to CRRT. In the CRRT arm, the randomized. Of the 208 non-randomized patients who majority (84.5%) of patients were treated with pumped received dialysis, 78 (20.9%) did not meet the hemodysystems (CVVHDF). Figure 1 shows the breakdown of namic eligibility criteria. Thirty (8.0%) were refused entry all randomized patients enrolled in the trial. No patients into the study by the treating physician. Fifty-two (13.9%)
were lost from the trial because of incomplete followwere not enrolled at the discretion of the consulting up. Fourteen patients received no treatment after rannephrologist. Sixteen (4.3%) refused directly or via the domization (CRRT 11 vs. IHD 3, P < 0.05) because of next of kin. Ten (2.7%) lacked an arterial access for an improvement in renal function in seven patients and CAVHDF, and 22 (5.9%) were enrolled in another study death in seven patients before dialytic therapy was or did not participate for other miscellaneous reasons, started. Twenty-one (12.7%) patients did not meet the We were able to ascertain the reasons for nonenrollment criteria outlined for an adequate trial of therapy. The in 77 of the 82 patients excluded by the physicians. Rea_ reasons for a limited treatment time were improvement sons for nonenrollment by the participating physicians in renal function in 9 patients and death in 12 patients included (1) emergent indication for dialysis (P = 60), (six in each group). Therefore, 35 (21.1%) patients failed that is, marked hyperkalemia (N = 7), acidosis (N = 3), to complete the trial (no treatment + limited treatment uremic complications (N = 18), and volume overload groups). Thirty-two (19.3%) patients crossed over from (N = 19); (2) specific request of transplant surgeons for one therapy to the other, 15 from IHD to CRRT and heart, lung, and liver transplant patients (N = 7); and 17 from CRRT to IHD. Table 1 spite randomization, there were significant differences generated by computer and a large block size (N = 10) in several key explanatory variables, including the prowas used. There were separate lists generated for each portion of men (83.3 % in CRRT vs. 68.3 % in IHD, P = center. Each center had the allocation in sealed opaque 0.02) and the proportion with hepatic failure (42.9% in envelopes through which the assignment was not visible. CRRT vs. 29.3% in IHD, P < 0.05). There were trends
The master list of random assignment was kept only at in the three severity-of-illness measures, all of which the statistician's home. Additionally, there were multiple suggested that patients assigned to CRRT were in fact physicians involved in the study at each center so that sicker: mean APACHE II (25.5 in CRRT vs. 23.7 in no single physician or other provider had the opportunity IHD, P < 0.08) and APACHE III (96.4 in CRRT vs.
of knowing (or guessing) what was the next patient's 87.7 in IHD, P < 0.045) score, and the mean number of assignment. Finally, we carried out an analysis of the failing organ systems (3.2 in CRRT vs. 3.0 in IHD, P < sequence of enrollment of all persons in relationship to 0.121);74.2% of the IHD group and 78.5% of the CRRT those who were randomized. There was no evidence group (P = NS) were volume overloaded (defined as that eligible patients were systematically withheld from clinical evidence of fluid overload and fluid gain ---4 L randomization in preference for either of the two protofrom baseline) at the time of initiation of dialysis. We cols. Implementation of the randomization assignment investigated the possible reasons for these imbalances was also uniform for all patients. There was no discrepfollowing randomization. These included (1)center effect, ancy in assignments stated on the randomization lists (2) compromised randomization, and (3) chance. The and the initial therapy given to the patient. These internal distribution of patients into IHD and CRRT arms was investigations indicate that randomization was not cornuniform at all four centers (X2, P = NS), and there were promised. Therefore, the observed differences in patient large differences in APACHE III scores between the characteristics by treatment assignment are most likely CRRT and IHD groups at three of the four centers, different by chance alone., although none were statistically different due to small sample size. There were three possible reasons for a ICU and in-hospital mortality failure of randomization: (1) improper random sequence
In the intent-to-treat population, overall ICU and ingeneration, (2) inadequate allocation concealment, and hospital mortality was 50.6 and 56.6%, respectively, well (3) problematic implementation. We investigated each below levels typically reported in the literature. On unadof these possibilities. The randomization sequence was justed analysis, 28 day all cause and ICU mortality were APACHEIIIscore at randomization groups, similar and were significantly increased with CRRT corn- to CRRT had the highest mortality rates (ICU and hospio, confidence interval. tal 86.7%) in comparison to those who crossed over from CRRT to IHD (ICU 41.2% and hospital mortality 47.1%; P < 0.02).
tality, the relative contribution of each of these variables was evaluated in a multivariable stepwise logistic-regresComorbid conditions and severity of illness sion analysis, including group assignment as an indepenSince there were significant differences in patient chardent explanatory variable. Hepatic failure, APACHE III acteristics between the two groups, we evaluated the assoscores, and the OSF score were independently related ciations of these characteristics with ICU and in-hospital to ICU mortality (Table 2 ). Gender and hepatic failure mortality. Men were more likely to die during the study were correlated; men were twice as likely to have hepatic than women (54 vs. 40%, P < 0.054), as were patients failure as women, although the difference did not reach with hepatic failure (76.4 vs. 35.1% in patients without statistical significance (×2,p = 0.10). Randomization to hepatic failure, P < 0.05). When patients were stratified CRRT or IHD was not independently associated with by ranking into tertiles based on their APACHE III mortality after adjustment for these unbalanced covariscores at the time of randomization, ICU and in-hospital ates, suggesting that the differences in mortality observed mortality were directly related to the degree of severity between CRRT and IHD could be attributable to comorof illness. A similar trend was observed when patients were stratified based on the OSF score at the time of bidity and severity of illness, rather than dialysis modrandomization. In a further evaluation of the association ality. Indeed, the adjusted odds of death associated with of severity of illness with mortality within the CRRT CRRT was 1.58 (95% CI 0.7 to 3.3). A time-to-event and IHD groups, within each stratum of APACHE III analysis was conducted using proportional hazards (Cox) scores there was no significant difference in mortality regression. Using this alternative method, there was a between CRRT and IHD (Fig. 2) .
significant increase in the hazard ratio, or unadjusted relative risk of death associated with CRRT (hazard ratio Multivariable analysis 1.64, CI, 1.08 to 2.48, P < 0.02). Again, adjustment by As the differences in patient characteristics and sever-APACHE III and other variables yielded the same conity of illness appeared to be major determinants of morclusions (hazard ratio 1.35, CI, 0.89 to 2.06, P --0.16). The mean duration of each IHD (3.1 hours) and CRRT thos e assigned to CRRT were left with CRI (P = 0.01) treatment (16.1 hours) was similar in the two groups. at hospital discharge or death. There was no significant Technical efficacy of the two modalities was assessed by difference in the frequency of CRI in the ARF versus evaluating the BUN and creatinine concentrations at ARF on CRI groups within each therapy assignment, various time points following initiation of dialysis. It is Of the surviving patients, 7% in the IHD and 14% in evident that the nature of IHD results in alternate peaks the CRRT group (P = NS) remained on maintenance and troughs of solute levels depending upon the fredialysis at hospital discharge. However, continuous therquency of dialysis, while CRRT is associated with a apy was associated with a significantly higher rate of comsteady state level of solutes [12] . A comparison of mean plete renal recovery in surviving patients who received daily BUN and creatinine levels between the two groups an adequate trial of therapy with no crossover (CRRT from the first dialysis treatment for the first 10 days is 92.3% vs. IHD 59.4%, P < 0.01). In addition, patients shown in Figure 3 . Continuous therapy resulted in lower who crossed over from CRRT to IHD had a significantly solute levels despite higher mean BUN values at the higher rate of complete recovery than those crossing start of therapy. Mean dialyzer BUN clearance was 21.5 over from IHD to CRRT (CRRT to IHD 44.7 % vs. IHD mL/min in patients treated with CRRT. Predialysis and to CRRT 6.7%, P < 0.01). Severity of illness was an post-dialysis BUN levels were not r_autinely available important determinant of renal recovery. The lowest to compute urea reduction ratios or Kt/V in the IHD rates of renal recovery were observed among patients patients. The efficacy of volume control in the two arms with APACHE III scores >100 (60.7% vs. 50.0% vs.
was compared by evaluating the cumulative fluid balance 25.0% for APACHE III scores -<79, 80 to 100 and >100, in each patient. Since CRRT techniques have an inherent respectively, P < 0.001). Similar findings were seen with advantage in this regard, we additionally assessed the ability of each protocol to achieve the stated goal for increasing APACHE II and OSF scores. Finally, renal fluid removal. More than one fourth (28.8%) of the IHD recovery was rare in patients who died.
treatments were unable to achieve the stated fluid goals.
Length of stay
It is difficult to assess a similar parameter for CRRT, since the duration of CRRT typically far exceeds that As the timing of nephrology consultation and patient of IHD, and short-term ultrafiltration goals are less wellenrollment into the study varied in relationship to the defined. Fewer than i in 10 (9%) CRRT treatments fell patient's admission to the hospital and ICU, the LOS short of the desired ultrafiltration goal. was calculated from the time of randomization. ICU LOS was similar in both groups using an intent-to-treat Technical complications analysis (CRRT 15.1 vs. IHD 16.7 days, P = NS). HospiData were accumulated on the incidence of technical tal LOS was significantly reduced for patients who recomplications related to access, anticoagulation, and ceived CRRT as the initial therapy only (CRRT 17.1 vs. pump use. For CRRT techniques, we distinguished be-IHD 26.3 days, P < 0.01). This difference in part may tween arteriovenous techniques (CAVHDF) and venobe related to the higher ICU mortality rate observed in venous techniques (CVVHDF)as the access and driving the CRRT arm. Patients who received both therapies forces are different. Arterial access was difficult to obtain had longer ICU and hospital lengths of stay. Higher in 3 out of 32 patients with CAVHDF and required APACHE III and OSF scores were associated with multiple attempts. Difficulties in obtaining venous access shorter LOS, reflecting higher mortality rates with higher were encountered in 5.3% cases of CAVHDF, 6.1% scores. Similarly, survivors had longer ICU lengths of IHD, and 9.5% in CVVHDF. Arterial access clotting stay than nonsurvivors, was seen in 0.3% of all cases, while venous access clotting was more frequent and occurred in 1.5% of all cases, and Control of azotemia and volume overload was equally frequent in the CRRT and IHD techniques. Using an intention to treat analysis of the 166 randomTubing disconnection was seen in 0.2% of IHD and ized patients, we found that the total number of treat-0.3% of CRRT. Blood loss >50 mL attributable to the ments was slightly lower in the group assigned to CRRT procedure occurred in 0.25 of IHD and 6.3% of (8.07) than in the group assigned to IHD (8.67), although CVVHDF procedures. Membrane leaks were seen in the difference is not statistically significant (P = 0.75).
0.2% of CVVHDF, 0.9% of CAVHDF techniques, and As some patients in each group crossed over, 82 patients were not observed in IHD. Restricting the analysis to higher for CRRT ($338) than that for IHD ($66) with the sec). All the bleeding complications were seen in heparin major contributor for CRRT being the dialysate (33% of CAVHDF procedures. None of the citrate anticoagutotal cost) followed by the cost of the filters (20%) and lated IHD (N = 26) or CRRT days (N = 284) had any the rental costs of infusion pumps (20%). The labor costs episodes of bleeding, while 0.7% of the saline anticoagufor IHD ($216) and CRRT ($205) were similar. The total lated IHD (N = 129), and none of the saline flush CRRT direct cost per treatment was much higher for CRRT (N = 62) had bleeding complications. Metabolic complications were more common in CRRT than IHD: hyper-($543) compared with IHD ($282); the overall cost of natremia (defined as Na >145; IHD 12.0% vs. CRRT dialysis also was affected by the number of treatments. 22.0%, P < 0.001) and alkalemia (pH 7.44 and bicar-
The total direct cost of dialysis was affected by both the bonate >28; IHD 9.8% vs. CRRT i5.6%, P < 0.02).
cost per treatment and the number of treatments reHypernatremia was more common in patients on saline ceived. Using an intention-to-treat analysis of the 166 flush or citrate anticoagulation (saline IHD 15.8% vs.
randomized patients, the total number of treatments was saline CRRT 21.4, P = NS; citrate IHD 11.1% vs. citrate slightly lower in the group assigned to CRRT (7.9) than CRRT 26.8%, P = NS). Alkalemia was most commonly in the group assigned to IHD (8.4), although the difseen in citrate anticoagulated procedures (citrate IHD ference was not statistically significant (P = 0.77). Some 29.6% vs. citrate CRRT 18.8%, P = NS), but was also patients in each group crossed over, 82 patients assigned to present in patients on heparin and saline flush anticoagu-IHD averaged 5.8 IHD treatments and 2.6 CRRT treatlation. The incidence of hypernatremia was similar in ments per person. The 84 patients assigned to CRRT CAVHDF (18.8%) and CVVHDF (23.0%, P = NS) averaged 1.3 IHD treatments and 6.6 CRRT treatments procedures, while alkalemia was more common with per person. Total per patient treatment costs for CRRT CAVHDF (21.2%) than CVVHDF (14.1%, P = NS).
were $3946 and $3077 for IHD (P = NS).
DISCUSSION
transfer out of intensive care, improved hemodynamic Contemporary management of ARF requiring dialysis stability, and resolution of volume overload. in the ICU includes a decision regarding the choice of It may be unrealistic to assume that a single decision dialysis modality, including IHD, peritoneal dialysis, and in the complex care of a critically ill patient could significontinuous hemodialysis, hemofiltration, and hemodiacantly influence survival. Mortality in the critically ill pafiltration. This study was designed to assess whether the tient is likely to be influenced by several factors unrelated type of dialysis modality (CRRT or IHD) used to treat to dialysis. It has been previously shown that the do-not-ARF in the ICU setting affects mortality, length of stay, resuscitate (DNR) status in the ICU setting influences and the likelihood of recovery of renal function. We hythe level of care administered and the eventual outcome pothesized that CRRT would be superior to IHD and [16] . We found that 7.1% of CRRT and 1.2% of IHD designed the trial to detect a 27% difference in ICU patients (P = NS)were made DNR prior to nephrology mortality, consultation. A perception of futility, among other facThe data show an overall mortality rate of 50.6%, contors, may affect practice and reduce the effectiveness siderably lower than the 60 to 80% rates reported in most of any intervention. It also should be noted that other published studies. This finding may be due to the clinidialysis-related factors were not controlled for, including cal trial effect reflecting an improved level of care or the timing of initiation, frequency, intensity, membrane may reflect the exclusion of patients too ill (hypotensive) choice, and dose of dialysis [17] . Although membrane to be randomized [13] . ICU mortality was 59.5% with choice has been variably shown to affect outcome from CRRT and 41.5% with IHD, a statistically significant ARF in recent studies, it is unlikely that membrane and clinically important difference. On the surface, these played a significant role in this study as all the CRRT findings support a survival advantage for IHD, although patients and the majority of IHD patients were treated further analysis provides an alternate explanation. It is with synthetic, noncellulosic membranes. Of course, a well recognized that severity of illness affects diseasemyriad of other conditions and their treatments (for exspecific outcomes in critically ill patients. In this study, ample, antibiotics, pressor agents, nutrition support) also may limit the specificity of an intervention such as a each of three indices of severity of illness (APACHE II change in dialysis modality. Swartz et al have recently and III and OSF) and two other clinical factors signifivalidated this viewpoint based on a retrospective comcantly associated with mortality (male gender and heparison of CWH versus IHD at a single center [18] . patic failure) were not evenly distributed, with more Using a Cox proportional hazards model, they showed severe nonrenal disease present in the patients randomthat the sickest patients are more likely to receive CRRT ized to CRRT [14, 15] . A detailed investigation failed as initial therapy and the underlying comorbidities acto reveal any specific factors accounting for these differcount for the difference in mortality observed in their ences. A logistic regression analysis adjusting for these patients. factors yielded a nonsignificant difference by treatment Mortality is an important outcome, although it may assignment. Furthermore, within strata of APACHE II not be the most appropriate primary outcome for ARF, and III scores, the relative mortality rates of CRRT and for many of the reasons cited previously in this article. IHD were not significantly different. Additionally, surRecovery of renal function and the need for short-and vival analysis of time to outcome (data not shown) did long-term dialysis may be more specific outcome meanot reveal any significant difference between the two sures to evaluate in the patient with ARF [19, 20] . Renal modalities. This pattern was apparent even when parecovery was rare in patients who died; however, survitients who did not receive any therapy in either group vors had varying levels of recovery of renal function, were excluded from the analysis. Together these findings and this appeared to be related to modality. Complete strongly suggest that the increased risk of death observed recovery of renal function was achieved more frequently in the CRRT group was the direct result of nonrenal in patients on CRRT compared with IHD. The mechadisease and that no definite statement can be made renism for this finding is unknown, but clearly warrants furgarding the superiority of one modality or the other, ther study. Intermittent dialysis may be associated with In our study, patients who crossed over from IHD to more frequent hemodynamic insults [21] . Alternatively, CRRT had an increase in their APACHE and OSF improved control of azotemia, clearance of middlemolescores at the time of crossover, while those who crossed cules [22] , and reduction in pulmonary, myocardial, gasover to IHD from CRRT had a decrease in their scores trointestinal, and other tissue edema may also play a role. (data not shown). These findings also highlight the imTechnical complications were similar in both groups portance of severity of illness and likely explain the pheand were largely related to anticoagulant use. Despite the nomenon described previously in this article among longer exposure to CRRT techniques, the overall frecrossover patients. Indeed, a change from CRRT to II-ID quency of complications was similar in the two groups. represents a complex array of events that may include Although the daily cost for CRRT is more than that for IHD, the difference in costs is largely related to the variable (for example, nutrition support, hemodynamic increased expense of materials. At the time this study support, timing of initiation, and dose of dialysis) and was done, CRRT was not as widely used as it is today, might materially influence outcomes in ARF. Standardand the cost of materials has changed. Additionally, how ization of several aspects of care and a significantly larger many filter kits are used can largely influence the costs sample will be required to answer optimally the quesfor CRRT. As CRRT techniques gain wider acceptance tions originally posed by this investigation. and methods to promote filter life are more universally adapted, it is likely that this difference in overall costs ACKNOWLEDGMENTS will be significantly reduced. care (IHD). Had the study been larger in number, the E-mail: rmehta@ucsd.edu power to detect a difference between modalities would have been greater, and the study would have been less likely to have experienced unbalanced randomization APPENDIX due to chance. It could be argued that selection of pa-
Criteria fororgansystemfailure
Cardiovascular. Heart rate ---54 per rain, mean arterial blood prestients excluded the majority of available patients because sure <--49mm Hg, occurrence of ventricular tachycardia and/or ventricof hemodynamic instability or physician choice. Howuiar fibrillation or other cardiac arrhythmias requiring continuous infuever, our analysis shows that the patients excluded by sion of antiarrhythmic, requirement for temporary pacemaker, intrathe physician's choice were not significantly different aorticballoonpumpor ventrieular assistdevices.
Neurological Glasgow coma score (GCS) <-6. When sedatives were than those enrolled. CRRT is most commonly reserved used,these wererecorded. for patients who are unable to receive IHD, and we had
Renal.Blood urea nitrogen (BUN) -<40 mg/100 mL or creatinine designed the protocol to exclude patients with MAP <70 ->2.0mg/100 mL for patients with no previous history of renal disease, an increase in creatinine >1 mg% for patients with pre-existing renal to avoid bias against IHD. CRRT is probably the most disease.
beneficial in patients who are hemodynamically unstable;
Hematological White blood cells (WBC) -<1000 mm 3, platelets however, it is difficult to design a study that enrolls only <-20,000 mm 3, hematocrit<-20%(not chronicrenal failure), requirement for platelet transfusions to maintain platelet levels >20,000/ram 3.
this group of patients. Additionally, the wide variation as the optimal timing of initiation, frequency, membrane, and dose of dialysis. Indeed, much of ARF practice has
